The U.S. appears to be on the brink of a winter surge in COVID-19 cases, but Johns Hopkins experts offer hope that this winter will be better than the last
Masked smiles, happy dances, and jumps for joy were tweeted out by JHU researchers, epidemiologists, and clinicians to capture the moment their young children got their first doses of the COVID-19 vaccine
'There are some early signs that we're headed in the wrong direction,' Hopkins epidemiologist Jennifer Nuzzo says while stressing importance of vaccine uptake
Emergency use authorization for Pfizer/BioNTech's vaccine is unlikely to lead to widespread vaccinations among the nation's 28 million 5- to 11-year-olds, Hopkins vaccine expert William Moss says
Johns Hopkins vaccine expert William Moss discusses inequities in the race to vaccinate the world against COVID-19 and why the U.S. and other wealthy nations should help poorer countries catch up
Will the COVID-19 vaccines protect transplant patients and others with compromised immune systems? That question has led Dorry Segev on a quest to protect those most vulnerable during the pandemic
FDA, CDC expected to finalize decisions about Pfizer booster doses in same week the company announced that studies of its vaccine for children show promising results